RxDoctor Payments Data
★ My doctorsLook up a doctor →

Katherine Standley, DO

Neurology · Tampa, FLNPI 1154556181

Payments from drug & device makers

$1,122,647in general payments, 2019–2025

Across 1,471 payments — averaging $763.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$232K
  • Amgen$210K
  • Eli Lilly$125K
  • Biohaven Pharmaceuticals, Inc.$124K
  • Sanofi$123K
  • Genentech USA, Inc.$59K
  • plus $251K from 40 others
$30,861in research payments, 2019–2025

Across 1 payment — averaging $30,861 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$31K

What the payments were for

  • Consulting fees$36,6415%
  • Speaking & faculty fees$639,44587%
  • Travel & lodging$36,1015%
  • Food & beverage$22,5683%
  • Education$550%

General payments by program year

19
20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis71$231,595
Amgen(2 entities)308$209,726
Eli Lilly4$124,612
Biohaven Pharmaceuticals, Inc.155$124,142
Sanofi167$122,708
Genentech USA, Inc.90$59,157
Biogen89$58,203
Teva Pharmaceuticals USA, Inc.115$44,467
Biohaven Pharmaceutical Holding Company Ltd.50$38,502
Lilly USA, LLC92$37,368
AbbVie(2 entities)131$34,479
Genentech, Inc.6$32,002
Impel Pharmaceuticals Inc.1$1,425
Bristol Myers Squibb24$1,203
UCB, Inc.21$394
EMD Serono, Inc.26$383
Supernus Pharmaceuticals, Inc.18$244
Johnson & Johnson9$182
Sunovion Pharmaceuticals Inc.10$172
Avanir Pharmaceuticals, Inc.6$157
E.r. Squibb & Sons, L.L.C.7$155
AstraZeneca4$109
Eisai Inc.5$90
Upsher-smith Laboratories LLC5$83
Lundbeck LLC3$82
Neurocrine Biosciences, Inc.4$78
Mallinckrodt Enterprises LLC3$72
Sanofi-aventis U.S. LLC3$69
CSL Behring3$64
Neurelis, Inc.4$63
Arbor Pharmaceuticals, Inc.3$60
Mallinckrodt Hospital Products Inc.3$60
SK Life Science, Inc.3$60
Assertio Therapeutics, Inc.3$59
Banner Life Sciences, LLC4$59
Amneal Pharmaceuticals LLC3$57
Zyla Life Sciences, Inc.3$43
Currax Pharmaceuticals LLC3$40
Jazz Pharmaceuticals Inc.2$37
Kyowa Kirin, Inc.2$37
Collegium Pharmaceutical, Inc.2$34
Grifols USA, LLC2$31
MDD US Operations, LLC1$24
Avion Pharmaceuticals1$23
Medtronic1$17
Acorda Therapeutics, Inc1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,122,647 in reported general payments places this provider in the 90th percentile of 1,434 neurology providers in Florida.

See all neurology providers in Florida →

Medicare billing

Part B allowed, 2024
$8,404
Medicare patients
45
Services billed
62

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Tampa

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →